Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Manuel Martin "EU has announced a €230 million loan by the EIB for the purchase of 88 million vaccines for the 92 world’s poorest countries. While 88 million doses is an important contribution, in reality this will cover less than 1.5% of the populations in those 92 LICs"- MSF's Sidney Wong 21:50 - 21 Sep 2020